Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Prenuvo-Powered Study Published in Nature Journal Links Smoking to Brain Shrinkage
- 7/23/2025 11:59:08 AM
- Prenuvo, the leading whole body MRI for proactive health screening, today announced its research has been published in Nature Partner Journal – Dementia (npj-Dementia).
- First Look at 2026 Draft Medicare Physician Fee Schedule Demonstrates Positive Steps Forward for Virtual Care, Says ATA Action
- 7/17/2025 11:21:50 AM
- ATA Action, the advocacy arm of the American Telemedicine Association, made initial comments on the 2026 Medicare Physician Fee Schedule (PFS) proposed rule posted by the Centers for Medicare & Medicaid Services (CMS).
- Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
- 7/17/2025 11:12:53 AM
- Ad hoc announcement pursuant to Art. 53 LR • Mukul Mehta, currently Head of Business Planning and Analysis (BPA), Digital Finance and Tax, has been appointed Chief Financial Officer, effective March 16, 2026, and will join the Executive Committee (ECN) • After an extraordinary 22-year career at Novartis and more than 12 years as a member of the ECN, Harry Kirsch …
- Sanofi announces extension of Blueprint tender offer
- 7/17/2025 10:54:39 AM
- Sanofi today announces that Rothko Merger Sub, Inc., a wholly owned subsidiary of Sanofi, has extended the expiration date of its tender offer to purchase all of the outstanding shares of common stock, par value $0.001 per share of Blueprint Medicines Corporation for $129.00 per share in cash, plus one non-transferable contractual contingent right per share, representing the …
- How to more efficiently study complex treatment interactions
- 7/16/2025 4:50:55 AM
- MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their approach allows scientists to efficiently estimate how combinations of treatments will affect a group of units, such as cells, enabling a researcher to perform fewer costly experiments while gathering more accurate data.
- Richard Young Set to Showcase Guide for Those Recently Diagnosed with Diabetes, Coming Soon To A Book Festival at Printers Row, Chicago
- 7/15/2025 2:20:11 PM
- Most people who would meet Richard Young wouldn’t know he was an advocate for diabetes awareness. He spent over 20 years in video and filmmaking at Raytheon Aircraft.
- Johnson & Johnson Marks 25 Years of Neurovascular Care with New Innovation Highlights at SNIS 2025
- 7/15/2025 12:14:11 PM
- Johnson & Johnson MedTech, a leader in neurovascular care, announced its upcoming data presentations and onsite activities at the 2025 Society of NeuroInterventional Surgery (SNIS) 22nd Annual Meeting & Fellows Course July 14-17 in Nashville, Tenn.
- Senegal joins growing list of countries that have eliminated trachoma
- 7/15/2025 11:11:33 AM
- The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO’s African Region to have achieved this feat.
- ConV2X 2025 Announces “Smart Tech Transformation in Healthcare” Event in NYC – Registration & Sponsorship Now Open
- 7/14/2025 8:00:00 AM
- The highly anticipated ConV2X 2025: Smart Tech Transformation in Healthcare is set to take place October 30-31, 2025, at the historic GE Building, 570 Lexington Ave, 12th Floor, New York City.
- Ryght AI Announces Partnership with Winship Cancer Institute for AI-powered Clinical Trials
- 7/11/2025 11:07:54 AM
- Ryght, a leader in real-time generative AI healthcare technology for clinical research, has announced that the prestigious Winship Cancer Institute of Emory University has joined its unique Ryght Research Network.
- Pilot Study Demonstrates Feasibility of Digital Tool for Dietary Goal Setting in Primary Care Diabetes Management
- 7/9/2025 2:16:55 PM
- A recent study in the Journal of Nutrition Education and Behavior, published by Elsevier, evaluated the feasibility of Nutri, a user-centered digital platform designed to support personalized, evidence-based diet goal setting during routine primary care visits for patients with type 2 diabetes.
- WHO, UNICEF update country tracker on water, sanitation and hygiene in health-care facilities, showing progress across 107 countries
- 7/9/2025 2:12:38 PM
- The World Health Organization (WHO) and UNICEF have released an updated country progress tracker that shows how countries are advancing efforts to improve water, sanitation, hygiene (WASH) and waste services in health-care facilities.
- Implantable device could save diabetes patients from dangerously low blood sugar
- 7/9/2025 1:20:21 PM
- For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is injecting a hormone called glucagon.
- Imfinzi approved in the EU as first and only perioperative immunotherapy for muscle-invasive bladder cancer
- 7/8/2025 1:31:49 PM
- AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).
- Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
- 7/8/2025 1:14:28 PM
- Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and only approved treatment for bipolar I and II depression as an adjunctive and monotherapy With the addition of CAPLYTA® to Johnson & Johnson’s robust …
- Prenuvo-Enabled Research Wins 2025 Journal of Alzheimer’s Disease Alzheimer Award
- 7/8/2025 11:46:59 AM
- Prenuvo, the leading whole-body MRI for proactive health screening, today announced research powered by its imaging dataset has received the prestigious 2025 Alzheimer Award from the Journal of Alzheimer’s Disease (JAD).
- Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
- 7/8/2025 10:57:40 AM
- Sirtex Medical (“Sirtex”), a leading manufacturer of interventional oncology solutions, announced that the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma (HCC) in the United States.
- New website on cholera control goes live
- 7/7/2025 10:40:17 AM
- The Global Task Force on Cholera Control (GTFCC), which brings together more than 50 nongovernmental organizations, academic institutions and UN agencies, and is hosted by the World Health Organization, has launched a new website.
- ConV2X Drops Draft Agenda for 2025 Decentralized Health & Life Sciences Event
- 7/7/2025 8:00:00 AM
- ConV2X, the premier conference for emerging and decentralized technologies in healthcare and life sciences, has officially released the draft agenda for its highly anticipated event, ConV2X 2025: Driving Platforms & Decentralized Tech in Healthcare and Life Sciences, to be held September 25–26, 2025, in Cambridge, Massachusetts.
- FedEx Strengthens Healthcare Capabilities in China with CEIV Pharma Certification
- 7/4/2025 11:05:27 AM
- Federal Express Corporation, one of the world’s largest express transportation companies, announced recently that its hub at Guangzhou Baiyun International Airport, China (CAN) has been awarded the prestigious CEIV Pharma certification.